Device evaluation: the device has been returned and evaluated by product analysis on 12/08/2016 with the following findings: a review of the pump histories did not find any errors, alarms, or warnings associated with the complaint.The pump successfully completed a rewind, load, and prime sequence.The black box data and histories from the time of the alleged incident were overwritten therefore they were unavailable for review due to continued use of the pump.The available daily insulin delivery totals correctly reflected the user¿s programmed basal rates.The pump passed delivery accuracy testing and was found to be delivering within required specifications.The insulin on board was found to functioning properly but the pump information for the complaint date was overwritten therefore the investigation was unable to duplicate the initial complaint about an ¿inaccurate delivery¿ issue.Animas has conducted a review of the device history record for this pump and confirmed that it was operating within required specifications at the time of release.(b)(4).
|